Arterium Corporation* has expanded its product portfolio with a new antibacterial medication – Urofoscin.

Arterium corporation has added to its product range Nokson, an all-new modern soporific and sedative drug.

In January 2017, Supplement 2.1 to the 2nd edition of State Pharmacopoeia of Ukraine (SPhU) came into effect. It includes monographs on the active ingredient of Thiotriazolin (tiazotic acid morpholinium salt) and the drug’s finished dosage forms.

Arterium Corporation has launched a website for its veterinary drug Auricap — www.auricap.ua — to raise awareness about the importance of regular ear cleaning as a part of pet care.

Kievmedpreparat, a part of Arterium Corporation, has confirmed its compliance with Good Manufacturing Practices (GMP).

Arterium Corporation's Sedavit will be sold in new packaging starting January — the carton design has been overhauled for tablets and oral solution alike.